Neuromuscular Disorders

Patient Distressed by Overturn of California End of Life Option Act

Patient Distressed by Overturn of California End of Life Option Act

Patient with ALS describes assisted death as last element of control, while losing control over his body.

Sensor Array May Detect De Novo Parkinson Disease in Breath

Sensor Array May Detect De Novo Parkinson Disease in Breath

Sensitivity, specificity, accuracy values of 79, 84, and 81% for detecting PD from controls.

Weighing the Risks of Deep Brain Stimulation

Weighing the Risks of Deep Brain Stimulation

DBS has been known to generate other movement-related disorders such as dyskinesias, blepharospasm, and hypokinesia.

Amyotrophic Lateral Sclerosis: Update for the Primary Care Clinician

Amyotrophic Lateral Sclerosis: Update for the Primary Care Clinician

Patients with ALS require multidisciplinary care and rehabilitative interventions; maximizing independent function and quality of life are the goals.

Cerebral palsy, epilepsy risk associated with lower Apgar score

Cerebral palsy, epilepsy risk associated with lower Apgar score

By

An inverse relation was observed between epilepsy and cerebral palsy and 5-minute and 10-minute Apgar scores.

Long-term memory enhanced by electrical stimulation of the amygdala

Long-term memory enhanced by electrical stimulation of the amygdala

By

Modulate electrical stimulation of the amygdala may improve declarative memory without provoking any emotional reaction.

Emflaza approved by FDA for Duchenne muscular dystrophy

Emflaza approved by FDA for Duchenne muscular dystrophy

The corticosteroid was approved to treat Duchenne muscular dystrophy in patients 5 years and older.

Sign Up for Free e-newsletters